Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Boston Scientific (BSX) stock in plain English

Free brief · no signupStart here
BSXPublished Nov 13, 2026
Boston Scientific Corp
Healthcare · Medical Devices
Manufactures and sells specialty medical hardware including cardiac pacemakers, stents, endoscopy equipment, and neuromodulation implants.
Assets:
48,000 employees worldwideoperates manufacturing plants across twelve countries
WATCHMAN implant lineflagship cardiovascular device for stroke prevention in arrhythmia
25,000 active patentsprotects an extensive global portfolio of medical technology designs
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

65
OPS ScoreOperating finances
Latest quote
-1.49%$42.99
$62.31B
18.2×
$21.05B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was BSX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Boston Scientific (BSX) do?

Boston Scientific Corp (BSX) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures and sells specialty medical hardware including cardiac pacemakers, stents, endoscopy equipment, and neuromodulation implants. It develops and manufactures minimally invasive devices that treat cardiovascular, respiratory, digestive, and. It is worth $62.31B on the market and sold $21.05B over the last year.

Market cap
$62.31B
P/E ratio
18.2×
Annual sales
$21.05B
Sector
Healthcare
Industry
Medical Devices
Brief updated
Nov 13, 2026

Brands and businesses behind BSX

  • WATCHMAN: An implantable heart closure device that prevents stroke in patients with non-valvular atrial fibrillation.
  • FARAPULSE: A pulsed field ablation system that treats atrial fibrillation by targeting heart tissue with non-thermal electrical fields.
  • SpyGlass: A single-use digital visualization catheter system used by gastroenterologists to inspect bile and pancreatic ducts.
  • AXIOS: A specialized stent delivery system allowing endoscopic drainage of fluid collections from the pancreas.
  • WaveWriter Alpha: A family of spinal cord stimulation systems that manage severe chronic pain using personalized electrical signals.

BSX’s flags, in plain English

Each flag is a number from Boston Scientific’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Wide Gross Margin

Gross margin of 65.6% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Still Climbing

Sales up 15.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Low debt

Low debt, only 47% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Priced for Perfection

The price is running well ahead of the growth. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about BSX

How big is Boston Scientific?

Boston Scientific’s market cap is $62.31B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $21.05B: what customers paid the company over the last year, before any costs.

What is BSX’s P/E ratio?

BSX’s P/E ratio is 18.2×. Investors pay about 18.2 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with BSX?

Product liability lawsuits and regulatory recall actions over implanted hardware frequently generate substantial legal expenses. That is one risk on Boston Scientific’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Boston Scientific’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BSX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card